The US pancreatic stents market is supported by the high volume of gastrointestinal and pancreatic procedures, expanding use of endoscopic interventions, and continued investments in advanced healthcare technologies. The country’s strong network of hospitals, ambulatory surgical centers, and specialized gastroenterology facilities facilitates the adoption of pancreatic stents for managing conditions such as pancreatic duct obstruction and postoperative complications. In addition, ongoing technological developments and the increasing preference for minimally invasive treatment approaches are expected to create further opportunities for market growth.

According to The Insight Partners, Global Pancreatic Stents Market size is projected to reach US$ 1,537.5 million by 2034 from US$ 823.93 million in 2025. The market is anticipated to register a CAGR of 8.11% during the forecast period 2026–2034. The increasing adoption of advanced endoscopic retrograde cholangiopancreatography (ERCP) procedures and growing awareness regarding early diagnosis and treatment of pancreatic diseases are expected to fuel market expansion over the coming years.

The global pancreatic stents market is witnessing significant growth due to the increasing prevalence of pancreatic disorders, rising demand for minimally invasive procedures, and continuous advancements in endoscopic technologies. Pancreatic stents are widely used in the treatment of pancreatic duct strictures, pancreatic cancer, chronic pancreatitis, and post-surgical complications. These medical devices help maintain ductal patency and improve pancreatic drainage, thereby reducing patient discomfort and improving clinical outcomes.

Get a Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00011446

One of the major drivers accelerating the growth of the pancreatic stents market is the rising global incidence of pancreatic cancer and chronic pancreatitis. Pancreatic cancer remains one of the deadliest cancers worldwide due to late diagnosis and limited treatment options. Pancreatic stents are extensively utilized to relieve duct obstruction and manage complications associated with these diseases. Furthermore, the increasing geriatric population, which is more susceptible to gastrointestinal and pancreatic disorders, is contributing to the growing demand for pancreatic stenting procedures.

Another significant factor supporting market growth is the increasing preference for minimally invasive treatment methods. Healthcare providers and patients are increasingly opting for endoscopic procedures due to benefits such as reduced hospital stays, faster recovery, lower procedural risks, and minimized post-operative complications. Technological advancements in stent materials, design, and flexibility are also improving procedural success rates and patient outcomes. The development of biodegradable and self-expandable metal stents is expected to create lucrative growth opportunities for manufacturers operating in this market.

Rising Technological Advancements Supporting Market Growth

Continuous innovation in stent technologies is transforming the pancreatic stents industry. Manufacturers are focusing on developing advanced stents with enhanced biocompatibility, anti-migration properties, and improved drainage capabilities. The growing adoption of plastic stents and self-expandable metallic stents (SEMS) is improving treatment efficiency for complex pancreatic conditions.

Additionally, the integration of imaging technologies with endoscopic procedures is enhancing diagnostic accuracy and treatment precision. Healthcare institutions are increasingly investing in advanced gastroenterology infrastructure, which is further driving demand for pancreatic stents globally. Favorable reimbursement policies in developed countries and increased healthcare spending in emerging economies are also positively influencing market growth.

Increasing Healthcare Infrastructure in Emerging Economies

Emerging economies across Asia Pacific, Latin America, and the Middle East are becoming attractive markets for pancreatic stent manufacturers. Rapid urbanization, expanding healthcare infrastructure, and improving access to advanced medical treatments are creating favorable conditions for market growth. Countries such as China and India are witnessing rising investments in healthcare facilities and diagnostic centers, enabling greater adoption of minimally invasive gastrointestinal procedures.

Furthermore, growing medical tourism in developing regions is contributing to the demand for advanced pancreatic treatment devices. Patients are increasingly seeking cost-effective treatment options in countries offering high-quality healthcare services at affordable prices. This trend is expected to support the expansion of the pancreatic stents market throughout the forecast period.

Market Challenges

Despite strong growth prospects, the pancreatic stents market faces several challenges. High procedural costs associated with advanced endoscopic treatments may limit adoption in low-income regions. Additionally, complications related to stent migration, infection risks, and occlusion remain significant concerns among healthcare providers. Strict regulatory approval processes for medical devices may also hinder the timely launch of innovative products.

However, ongoing research and development activities aimed at improving stent safety and performance are expected to mitigate these challenges. Increasing collaborations between medical device companies and healthcare institutions are likely to accelerate innovation and improve market competitiveness.

Key Market Segments

Based on product type, the pancreatic stents market is segmented into plastic pancreatic stents and metal pancreatic stents. Among these, plastic stents currently hold a substantial market share due to their affordability and widespread usage in temporary pancreatic drainage procedures. However, metal stents are expected to witness faster growth owing to their longer patency rates and reduced need for replacement procedures.

By end user, hospitals and specialty clinics dominate the market due to the increasing number of gastrointestinal procedures performed in these settings. Ambulatory surgical centers are also gaining traction as minimally invasive treatments become more common worldwide.

Regional Insights

North America currently dominates the pancreatic stents market due to the high prevalence of pancreatic diseases, advanced healthcare infrastructure, and strong adoption of innovative medical technologies. The United States remains a major contributor to regional growth because of increasing healthcare expenditure and the presence of leading medical device manufacturers.

Europe also represents a significant market share, supported by favorable reimbursement systems and rising awareness regarding pancreatic disease management. Meanwhile, the Asia Pacific region is anticipated to register the highest CAGR during the forecast period due to expanding healthcare access, rising patient populations, and increasing investments in medical technology.

Leading Companies in the Pancreatic Stents Market

Several major players are actively focusing on product innovation, strategic collaborations, mergers, and acquisitions to strengthen their market presence. Key companies operating in the pancreatic stents market include:

• Becton, Dickinson and Company,
• Boston Scientific Corporation
• C. R. Bard
• Cantel Medical Corporation
• ConMed Corporation
• Cook Group Incorporated
• Diagmed Healthcare Ltd
• ENDO-FLEX GmbH
• Merit Medical Systems, Inc.
• Olympus Corporation

These companies are emphasizing the development of innovative stent technologies to address the increasing demand for effective pancreatic disease management solutions.

Future Outlook

The pancreatic stents market is expected to experience robust growth through 2034, driven by the increasing prevalence of pancreatic disorders, rising preference for minimally invasive procedures, and continuous technological advancements in stent design. Expanding healthcare infrastructure in emerging economies and growing awareness regarding early disease diagnosis are also contributing to market expansion. As manufacturers continue to innovate and healthcare providers increasingly adopt advanced endoscopic solutions, the pancreatic stents market is poised for substantial development in the coming years.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish